奶牛乳腺炎无乳链球菌毒力相关因子

doi:10.11843/j.issn.0366-6964.2020.12.005

摘要/Abstract

摘要： 链球菌、金黄色葡萄球菌和大肠杆菌是引起奶牛乳腺炎的3大病原菌，在链球菌属中无乳链球菌是引起奶牛乳腺炎的重要病原菌之一，由无乳链球菌导致的乳腺炎约占隐性乳腺炎发病率的56.25%。无乳链球菌入侵奶牛乳腺的过程主要包括感染、黏附上皮细胞、侵入上皮细胞、损伤机体和免疫逃避等过程。无乳链球菌的毒力因子具有附着和侵袭机体细胞的作用，使菌体在奶牛乳腺表面形成生物被膜，进而干扰机体的正常免疫功能并引起疾病。本文主要阐述了无乳链球菌在入侵乳腺组织过程中发挥主要作用的毒力因子的种类、作用机制以及调控过程，旨在通过抑制其相关毒力因子的活性，从而阻断无乳链球菌在乳腺中感染和传播，进而为预防和治疗链球菌型乳腺炎提供新的思路。

关键词: 无乳链球菌, 毒力因子, 奶牛, 乳腺炎

Abstract: Streptococcus, Staphylococcus aureus, and Escherichia coli are the three major pathogens causing mastitis in dairy cows, and Streptococcus agalactiae (S.agalactiae) in Streptoco-ccus is one of the important pathogens causing mastitis in dairy cows, which accounts for around 56.25% of the incidence of sub-clinic mastitis. The process of S.agalactiae invasion mammary glands of dairy cows mainly includes:infection, adhesion, invasion, and then damage the mammary tissue and entail the inflammation. The virulence factor of S. agalactiae has the function of attaching and invading the mammary gland epithelial cells so that the bacteria could form the biofilm on the surface. After infection, the irritation of the mammary tissues by infectious processes serves to the immune response. In this paper, we summarized the types, mechanism, and regulation process of S. agalactiae virulence factors which plays a major role in the invasion of mastitis, aimed to show the activity of S. agalactiae by inhibiting the activity of its related virulence factors in preventing dairy cow mastitis and provide new ideas for the treatment.

Key words: Streptococcus agalactiae, virulence factor, dairy cow, mastitis

中图分类号:

S857.26

吴富鑫, 熊本海, 童津津, 蒋林树. 奶牛乳腺炎无乳链球菌毒力相关因子[J]. 畜牧兽医学报, 2020, 51(12): 2954-2963.

WU Fuxin, XIONG Benhai, TONG Jinjin, JIANG Linshu. Advances on Virulence Factors of Streptococcus agalactiae of Dairy Cows Mastitis[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(12): 2954-2963.

参考文献 62

[1]	GUSSMANN M, STEENEVELD W, KIRKEBY C, et al. Economic and epidemiological impact of different intervention strategies for subclinical and clinical mastitis[J]. Prev Vet Med, 2019, 166:78-85.
[2]	LAKEW B T, FAYERA T, ALI Y M. Risk factors for bovine mastitis with the isolation and identification of Streptococcus agalactiae from farms in and around Haramaya district, eastern Ethiopia[J]. Trop Anim Health Prod, 2019, 51(6):1507-1513.
[3]	VORNHAGEN J, WALDORF K M A, RAJAGOPAL L. Perinatal group B streptococcal infections:virulence factors, immunity, and prevention strategies[J]. Trends Microbiol, 2017, 25(11):919-931.
[4]	SIEMENS N, OEHMCKE-HECHT S, HOßMANN J, et al. Prothrombotic and proinflammatory activities of the β-hemolytic group B streptococcal pigment[J]. J Innate Immu, 2020, 12(4):291-303.
[5]	GORI A, HARRISON O B, MLIA E, et al. Pan-GWAS of Streptococcus agalactiae highlights lineage-specific genes associated with virulence and niche adaptation[J]. mBio, 2020, 11(3):e00728-20.
[6]	ARMISTEAD B, OLER E, WALDORF K A, et al. The double life of Group B Streptococcus:asymptomatic colonizer and potent pathogen[J]. J Mol Biol, 2019, 431(16):2914-2931.
[7]	CARVALHO-CASTRO G A, SILVA J R, PAIVA L V, et al. Molecular epidemiology of Streptococcus agalactiae isolated from mastitis in Brazilian dairy herds[J]. Braz J Microbiol, 2017, 48(3):551-559.
[8]	PICKERING A C, VITRY P, PRYSTOPIUK V, et al. Host-specialized fibrinogen-binding by a bacterial surface protein promotes biofilm formation and innate immune evasion[J]. PLoS Pathog, 2019, 15(6):e1007816.
[9]	THOMAS L, COOK L. Two-component signal transduction systems in the human pathogen, Streptococcus agalactiae[J]. Infect Immun, 2020, 88(7):e00931-19.
[10]	SAFADI R A, MEREGHETTI L, SALLOUM M, et al. Two-component system RgfA/C Activates the fbsB gene encoding major fibrinogen-binding protein in highly virulent CC17 clone group B streptococcus[J]. PLoS One, 2011, 6(2):e14658.
[11]	RAGUNATHAN P, PONNURAJ K. Expression, purification and structural analysis of a fibrinogen receptor FbsA from Streptococcus agalactiae[J]. Protein J, 2011, 30(3):159-166.
[12]	DEVI A S, PONNURAJ K. Cloning, expression, purification and ligand binding studies of novel fibrinogen-binding protein FbsB of Streptococcus agalactiae[J]. Protein Expr Purif, 2010, 74(2):148-155.
[13]	杜琳, 吕天星, 赵红梅, 等. 无乳链球菌CP+Sip-FbsA偶联蛋白免疫学特性的研究[J]. 中国预防兽医学报, 2016, 38(12):976-980.DU L, LV T X, ZHAO H M, et al. The immune effect of Streptococcus agalactiae recombinant CP+Sip-FbsA fusion protein on S. agalactiae induced mouse mastitis[J]. Chinese Journal of Preventive Veterinary Medicine, 2016, 38(12):976-980. (in Chinese)
[14]	BUSCETTA M, PAPASERGI S, FIRON A, et al. FbsC, a novel fibrinogen-binding protein, promotes Streptococcus agalactiae-host cell interactions[J]. J Biol Chem, 2014, 289(30):21003-21015.
[15]	柴晨. 无乳链球菌α-enolase, PGK和GAPDH基因的克隆、表达及对罗非鱼免疫效果研究[D]. 广州:中山大学, 2017.CHAI C. Studies on cloning, expression and immune effect of α-enolase, PGK and GAPDH genes of Streptococcus lactobacillus on tilapia[D]. Guangzhou:Sun Yat-sen University, 2017. (in Chinese)
[16]	SEO H S, MINASOV G, SEEPERSAUD R, et al. Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae[J]. J Biol Chem, 2013, 288(50):35982-35996.
[17]	MISTOU M Y, DRAMSI S, BREGA S, et al. Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence[J]. J Bacteriol, 2009, 191(13):4195-4206.
[18]	SEIFERT K N, ADDERSON E E, WHITING A A, et al. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (ε) associated with a virulent lineage of serotype Ⅲ Streptococcus agalactiae[J]. Microbiology, 2006, 152(4):1029-1040.
[19]	PIETROCOLA G, ARCIOLA C R, RINDI S, et al. Streptococcus agalactiae Non-Pilus, cell wall-anchored proteins:involvement in colonization and pathogenesis and potential as vaccine candidates[J]. Front Immunol, 2018, 9:602.
[20]	GENDRIN C, LEMBO A, WHIDBEY C, et al. The sensor Histidine kinase RgfC affects group B streptococcal virulence factor expression independent of its response regulator RgfA[J]. Infect Immun, 2015, 83(3):1078-1088.
[21]	吴金花, 布日额, 王金良, 等. 奶牛乳腺炎无乳链球菌sip、pgk及FbsA基因主要抗原区域的融合表达及抗原性鉴定[J]. 中国兽医学报, 2017, 37(7):1292-1299.WU J H, BU R E, WANG J L, et al. Fusion expression of main antigen area of sip, pgk and FbsA subunit genes and the antigenicity identification in Streptococcus agalactiae for dairy cow mastitis[J]. Chinese Journal of Veterinary Science, 2017, 37(7):1292-1299. (in Chinese)
[22]	LIN S. Immunization of 13 amino acid peptide targeting Srr proteins provide a broad spectrum of protections against group B streptococcal infections[M]//2016 International Meeting of the Microbiological Society of Korea, 2016:166.
[23]	MAIONE D, MARGARIT I, RINAUDO C D, et al. Identification of a universal group B Streptococcus vaccine by multiple genome screen[J]. Science, 2005, 309(5731):148-150.
[24]	DRAMSI S, CALIOT E, BONNE I, et al. Assembly and role of pili in group B streptococci[J]. Mol Microbiol, 2006, 60(6):1401-1413.
[25]	白文丽, 王金良, 锡林高娃, 等. 奶牛乳腺炎无乳链球菌菌毛岛屿PI-2a骨架蛋白BP基因的克隆及其抗原性预测[J]. 中国病原生物学杂志, 2017, 12(4):294-297.BAI W L, WANG J L, XILIN G W, et al. Cloning and prediction of the antigenicity of a gene that codes for a pilus backbone protein (PI-2a) in Streptococcus agalactiae causing bovine mastitis[J]. Journal of Parasitic Biology, 2017, 12(4):294-297. (in Chinese)
[26]	MAELAND J A, AFSET J E, LYNG R V, et al. Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae[J]. Clinical Vaccine Immunol, 2015, 22(2):153-159.
[27]	KONG F R, GOWAN S, MARTIN D, et al. Molecular profiles of group B streptococcal surface protein antigen genes:relationship to molecular serotypes[J]. J Clinical Microbiol, 2002, 40(2):620-626.
[28]	BARON M J, FILMAN D J, PROPHETE G A, et al. Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells[J]. J Biol Chem, 2007, 282(14):10526-10536.
[29]	CRETI R, FABRETTI F, OREFICI G, et al. Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes[J]. J Clinical Microbiol, 2004, 42(3):1326-1329.
[30]	张保海, 罗梓丹, 芦彪, 等. 四川部分地区奶牛源无乳链球菌的分离鉴定、毒力基因检测及耐药性分析[J]. 西北农业学报, 2020, 29(3):327-333.ZHANG B H, LUO Z D, LU B, Isolation, Virulence gene test and drug resistance analysis of Streptococcus agalactiae from dairy cows in some areas of Sichuan[J]. Acta Agriculturae Boreali-occidentalis Sinica, 2020, 29(3):327-333. (in Chinese)
[31]	WÄSTFELT M, STÅLHAMMAR-CARLEMALM M, DELISSE A M, et al. Identification of a family of streptococcal surface proteins with extremely repetitive structure[J]. J Biol Chem, 1996, 271(31):18892-18897.
[32]	NAGARAJAN R, SANKAR S, PONNURAJ K. Crystal structure of GAPDH of Streptococcus agalactiae and characterization of its interaction with extracellular matrix molecules[J]. Microb Pathog, 2019, 127:359-367.
[33]	SPENCER B L, DENG L W, PATRAS K A, et al. Cas9 contributes to group B streptococcal colonization and disease[J]. Front Microbiol, 2019, 10:1930.
[34]	BOLDENOW E, GENDRIN C, NGO L, et al. Group B Streptococcus circumvents neutrophils and neutrophil extracellular traps during amniotic cavity invasion and preterm labor[J]. Sci Immunol, 2016, 1(4):eaah4576.
[35]	ROSA-FRAILE M, DRAMSI S, SPELLERBERG B. Group B streptococcal haemolysin and pigment, a tale of twins[J]. FEMS Microbiol Rev, 2014, 38(5):932-946.
[36]	布日额, 吴金花, 锡林高娃, 等. 牛乳腺炎无乳链球菌β溶血素基因cylE缺失突变株的构建[J]. 中国病原生物学杂志, 2019, 14(7):773-779.BU R E, WU J H, XILIN G W, et al. Construction of a β-hemolysin gene deletion mutant strain of bovine mastitis Streptococcus agalactiae[J]. Journal of Pathogen Biology, 2019, 14(7):773-779. (in Chinese)
[37]	杨学云, 李建军, 王蒴, 等. 改良格拉纳达培养基分离奶牛乳房炎奶样中无乳链球菌的效果评价[J]. 新疆农业科学, 2014, 51(11):2093-2098.YANG X Y, LI J J, WANG S, et al. Evaluation of the modified granada medium for detection of Streptococcus agalactiae from mastitis samples[J]. Xinjiang Agricultural Sciences, 2014, 51(11):2093-2098. (in Chinese)
[38]	阚威, 樊杰, 武小虎, 等. 奶牛乳房炎无乳链球菌的分离及PCR鉴定[J]. 中国兽医学报, 2014, 34(8):1261-1266.KAN W, FAN J, WU X H, et al. Isolation and PCR-identification of Streptococcus agalactiaee in milk sampled from mastitic dairy cows[J]. Chinese Journal of Veterinary Science, 2014, 34(8):1261-1266. (in Chinese)
[39]	BAKER J R, PRITCHARD D G. Action pattern and substrate specificity of the hyaluronan lyase from group B streptococci[J]. Biochem J, 2000, 348(2):465-471.
[40]	KOLAR S L, KYME P, TSENG C W, et al. Group B Streptococcus evades host immunity by degrading hyaluronan[J]. Cell Host Microbe, 2015, 18(6):694-704.
[41]	刘龙海. 奶牛乳房炎无乳链球菌血清型分布、耐药性及其相关基因的研究[D]. 北京:中国农业科学院, 2017.LIU L H. Distribution of serotypes, antimicrobial susceptibility and related genes of S. agalactiae isolates from mastitis cases[D]. Beijing:Chinese Academy of Agricultural Sciences, 2017. (in Chinese)
[42]	HEATH C. Evolution of Streptococcus iniae after vaccination and molecular underpinnings of capsular antigenicity[D]. Brisbane:The University of Queensland, 2016.
[43]	PODBIELSKI A, BLANKENSTEIN O, LVTTICKEN R. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor[J]. Me Microbiol Immunol, 1994, 183(5):239-256.
[44]	FOUAD M, ZAKARIA S, METWALLY L, et al. Detection of maternal colonization of group B Streptococcus by PCR targeting cfb and scpb genes[J]. J Microbiol Biotechnol Food Sci, 2016, 6(1):713-716.
[45]	VIEIRA L L, PEREZ A V, MACHADO M M, et al. Group B Streptococcus detection in pregnant women:comparison of qPCR assay, culture, and the Xpert GBS rapid test[J]. BMC Pregnancy Childbirth, 2019, 19(1):532.
[46]	王向柳. 奶牛乳腺炎三联苗田间试验及牛源无乳链球菌CAMP因子的克隆表达[D]. 乌鲁木齐:新疆农业大学, 2008.WANG X L. Field trial of triple inactivated vaccine against mastitis of cows and cloning and expression CAMP gene of Streptococcus agalactiae from mastitis milk[D]. Urumqi:Xinjiang Agricultural University, 2008. (in Chinese)
[47]	PAOLETTI L C, KASPER D L. Glycoconjugate vaccines to prevent group B streptococcal infections[J]. Expert Opin Biol Ther, 2003, 3(6):975-984.
[48]	SEVERI E, HOOD D W, THOMAS G H. Sialic acid utilization by bacterial pathogens[J]. Microbiology, 2007, 153(9):2817-2822.
[49]	姚晶, 任婧, 吴正钧, 等. 唾液酸化路易斯-X合成关键酶基因的克隆表达[J]. 中国生物工程杂志, 2011, 31(12):51-56.YAO J, REN J, WU Z J, et al. Cloning and expression of the key enzyme gene in biosynthesis of sialyl lewis X[J]. China Biotechnology, 2011, 31(12):51-56. (in Chinese)
[50]	TONG J, FU Y G, WU N H, et al. Sialic acid-dependent interaction of group B streptococci with influenza virus-infected cells reveals a novel adherence and invasion mechanism[J]. Cell Microbiol, 2018, 20(4):e12818.
[51]	LEWIS A L, CAO H Z, PATEL S K, et al. NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus[J]. J Biol Chem, 2007, 282(38):27562-27571.
[52]	TAMURA G S, KUYPERS J M, SMITH S, et al. Adherence of group B streptococci to cultured epithelial cells:roles of environmental factors and bacterial surface components[J]. Infect Immun, 1994, 62(6):2450-2458.
[53]	NIZET V, KIM K S, STINS M, et al. Invasion of brain microvascular endothelial cells by group B streptococci[J]. Infect Immun, 1997, 65(12):5074-5081.
[54]	FARHAT K, SAUTER K S, BRCIC M, et al. The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle[J]. Vet Immunol Immunopathol, 2008, 125(3-4):326-336.
[55]	POYART C, PELLEGRINI E, GAILLOT O, et al. Contribution of Mn-cofactored superoxide dismutuse (SodA) to the virulence of Streptococcus agalactiae[J]. Infect Immun,2001,69(8):5098-5106.
[56]	ZHANG H M, JIANG H R, FAN Y L, et al. Transcriptomics and iTRAQ-Proteomics analyses of bovine mammary tissue with Streptococcus agalactiae-induced mastitis[J]. J Agric Food Chem, 2018, 66(42):11188-11196.
[57]	BOHNSACK J F, CHANG J K, HILL H R. Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species[J]. Infect Immun, 1993, 61(4):1421-1426.
[58]	SANTILLAN D A, ANDRACKI M E, HUNTER S K. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase[J]. Am J Obstet Gynecol, 2008, 198(1):114.E1-114.E6.
[59]	MARQUES M B, KASPER D L, PANGBURN M K, et al. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci[J]. Infect Immun, 1992, 60(10):3986-3993.
[60]	MOULIN P, RONG V, SILVA A R E, et al. Defining the role of the Streptococcus agalactiae Sht-family proteins in zinc acquisition and complement evasion[J]. J Bacteriol, 2019, 201(8):e00757-18.
[61]	MAISEY H C, DORAN K S, NIZET V. Recent advances in understanding the molecular basis of group B Streptococcus virulence[J]. Exp Rev Mol Med, 2008, 10:e27.
[62]	PETERS J, PRICE J, LLEWELYN M. Staphylococcal and streptococcal infections[J]. Medicine, 2017, 45(12):727-734.